A randomized, open-label, multiple-dose, crossover study to investigate the pharmacokinetic drug interaction between rosuvastatin and telmisartan in healthy volunteer
Latest Information Update: 18 Sep 2019
Price :
$35 *
At a glance
- Drugs Rosuvastatin (Primary) ; Telmisartan (Primary)
- Indications Atherosclerosis; Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Acronyms YH16410 DDI
- Sponsors Yuhan
- 27 Nov 2013 New source identified and integrated: ClinicalTrials.gov record.
- 22 Nov 2013 Status changed from recruiting to completed, according to the ClinicalTrials.gov record.
- 15 Feb 2013 New trial record